A Study to Evaluate Raptiva in Subjects With Chronic Moderate or Worse Plaque Psoriasis Who Have Had an Inadequate Response to an Anti-TNF Agent
Clinical trial NCT00336973 · COMPLETED
Trial details
- NCT number
- NCT00336973
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2008-02-01
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.